He H - Search Results

1

Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma.

Yang G, Su X, Yang H, Luo G, Gao C, Zheng Y, Xie W, Huang M, Bei T, Bai Y, Wang Z, Cai P, He H, Xiang J, Cai M, Zhang Y, Qu C, Fu J, Liu Q, Hu Y, Zhong J, Huang Y, Guo Q, Zhang X. Yang G, et al. Among authors: he h. Ann Transl Med. 2021 Aug;9(15):1254. doi: 10.21037/atm-21-3352. Ann Transl Med. 2021. PMID: 34532391 Free PMC article.

2

The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China.

Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, Luo RZ, Yun JP, Xie D, Li YF, Cai MY. Li P, et al. BMC Cancer. 2015 May 7;15:370. doi: 10.1186/s12885-015-1370-2. BMC Cancer. 2015. PMID: 25947284 Free PMC article.

3

Evaluating Heterogeneity of Primary Lung Tumor Using Clinical Routine Magnetic Resonance Imaging and a Tumor Heterogeneity Index.

Hu N, Yin S, Li Q, He H, Zhong L, Gong NJ, Guo J, Cai P, Xie C, Liu H, Qiu B. Hu N, et al. Among authors: he h. Front Oncol. 2021 Jan 8;10:591485. doi: 10.3389/fonc.2020.591485. eCollection 2020. Front Oncol. 2021. PMID: 33542900 Free PMC article.

4

Are more courses of immunochemotherapy beneficial for the short-term outcome of locally advanced esophageal squamous cell carcinoma?

Huang Y, Su X, Guo Q, Luo G, He H, Cai P, Cai M, Yue H, Wang Z, Yang G, Lin P, Zhang X. Huang Y, et al. Among authors: he h. Thorac Cancer. 2023 May;14(13):1153-1161. doi: 10.1111/1759-7714.14843. Epub 2023 Mar 24. Thorac Cancer. 2023. PMID: 36960736 Free PMC article.

5

Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial.

Yang G, Su X, Huang Y, Luo G, Wang Z, Cai P, Zheng Y, Bei T, Huang M, Bai Y, He H, Xiang J, Cai M, Zhong J, Guo Q, Zhang X. Yang G, et al. Among authors: he h. J Transl Med. 2023 Jun 24;21(1):411. doi: 10.1186/s12967-023-04273-6. J Transl Med. 2023. PMID: 37355621 Free PMC article. Clinical Trial.

6

Comparing the outcomes of MR-based versus CT-based tumor delineation in locally advanced non-small cell lung cancer treated with hypo-fractionated radiotherapy and concurrent chemotherapy.

Zhang P, Ding S, Peng K, He H, Wang D, Zhou R, Wang B, Guo J, Liu H, Huang X, Xie C, Liu H, Qiu B. Zhang P, et al. Among authors: he h. Transl Lung Cancer Res. 2024 Nov 30;13(11):2890-2902. doi: 10.21037/tlcr-24-341. Epub 2024 Nov 6. Transl Lung Cancer Res. 2024. PMID: 39670014 Free PMC article.

7

Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.

Chen NB, Li QW, Zhu ZF, Wang YM, Cheng ZJ, Hui ZG, Guo SP, He HQ, Wang B, Huang XY, Li JB, Guo JY, Hu N, Ai XL, Zhou Y, Wang DQ, Liu FJ, Xie CM, Qiu B, Liu H. Chen NB, et al. Among authors: he hq. Radiat Oncol. 2020 Nov 10;15(1):260. doi: 10.1186/s13014-020-01704-2. Radiat Oncol. 2020. PMID: 33168045 Free PMC article.

8

Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapy.

Wang D, Qiu B, He H, Yin S, Peng K, Hu N, Guo J, Li Q, Chen N, Chu C, Liu F, Xie CM, Liu H. Wang D, et al. Among authors: he h. Radiother Oncol. 2022 Mar;168:211-220. doi: 10.1016/j.radonc.2022.01.042. Epub 2022 Feb 4. Radiother Oncol. 2022. PMID: 35131342

9

An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases.

Ding S, Liu B, Zheng S, Wang D, Liu M, Liu H, Zhang P, Peng K, He H, Zhou R, Guo J, Qiu B, Huang X, Liu H. Ding S, et al. Among authors: he h. Clin Transl Radiat Oncol. 2023 Feb 23;40:100602. doi: 10.1016/j.ctro.2023.100602. eCollection 2023 May. Clin Transl Radiat Oncol. 2023. PMID: 36910023 Free PMC article.

10

Correlation of K^trans derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy.

Wang D, Liu S, Fu J, Zhang P, Zheng S, Qiu B, Liu H, Ye Y, Guo J, Zhou Y, Jiang H, Yin S, He H, Xie C, Liu H. Wang D, et al. Among authors: he h. J Immunother Cancer. 2024 Jun 23;12(6):e008574. doi: 10.1136/jitc-2023-008574. J Immunother Cancer. 2024. PMID: 38910009 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,169 results

Search Page

Filters